蒽环类药物的发展历程 图 1. 蒽环类药物 [1] 蒽环类抗肿瘤抗生素（anthracycline anti-cancer antibiotics）或称蒽环糖苷类抗生素（anthracycline glycoside ...

近日，北京中医药大学东直门医院王勇教授和广州中医药大学王伟教授团队在Medicine Plus上发表综述文章“Anthracycline-induced cardiotoxicity: emerging mechanisms ...

The aim of this study was to determine the activity of anthracycline rechallenge using pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) previously treated with ...

Anthracycline chemotherapy drugs damage the DNA in cancer cells, so they cannot reproduce. They can treat several types of cancer. However, they can also cause a range of side effects ...

Combining anthracycline and taxane for early-stage operable breast cancer was more effective than either anthracycline or taxane chemotherapy alone in reducing breast cancer recurrence and death ...

All patients received two cycles of ATO therapy during consolidation 1, an additional two (SR) or three (HR) consolidation courses that included high-dose cytarabine and anthracycline, and maintenance ...

In September 2007, the FDA approved dexrazoxane hydrochloride injection for the treatment of extravasation resulting from intravenous anthracycline chemotherapy. Dexrazoxane (Zinecard, Pfizer ...

Of them, 189 received an anthracycline prior to trastuzumab, and 279 received trastuzumab alone. Mean LVEF at baseline was 62.6%, mean BMI was 28.4 kg/m 2, and 8.4% of the population had hypertension.

In young adults with acute myeloid leukemia (AML), intensification of the anthracycline dose during induction therapy has improved the rate of complete remission but not of overall survival.

Patients who have residual invasive carcinoma after the receipt of neoadjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)–negative breast cancer have poor prognoses.

Detailed information regarding therapeutic exposures was abstracted from medical records. Total anthracycline exposure was calculated by multiplying the cumulative dose per meter square of body ...